X

Health Care

Earnings Summary: A snapshot of Revvity’s (RVTY) Q3 2025 report

Revvity, Inc. (NYSE: RVTY), a provider of health science solutions and technologies, reported a decline in adjusted earnings for the…

Earnings Summary: Highlights of Boston Scientific’s Q3 2025 results

Medical device maker Boston Scientific Corporation (NYSE: BSX) on Wednesday reported financial results for the third quarter of 2025. The company…

Intuitive Surgical (ISRG) Q3 FY25 revenue and earnings beat estimates

Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) on Wednesday reported stronger-than-expected revenue and earnings for the third quarter of…

Infographic: How Thermo Fisher (TMO) performed in Q3 2025

Thermo Fisher Scientific Inc. (NYSE: TMO) reported its third quarter 2025 earnings results today. Revenue grew 5% year-over-year to $11.12…

Abbott Laboratories Q3 adj. earnings rise on higher sales; meet Street view

Abbott Laboratories (NYSE: ABT) reported higher sales and adjusted earnings for the third quarter of fiscal 2025. The healthcare company…

Kairos Pharma’s goal is to intervene early in resistance and re-sensitize cancer cells to therapy: CEO

Kairos Pharma, Ltd. (NYSE: KAPA) is a biopharma company developing a pipeline of targeted therapies for cancer patients with high…

JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q3 2025 financial results

Johnson & Johnson (NYSE: JNJ) reported its third quarter 2025 earnings results today. Reported sales increased 6.8% year-over-year to $24…

Our differentiation is validated by strong, sustainable unit economics: Prenetics CEO

Prenetics Global Limited (NASDAQ: PRE), headquartered in Hong Kong, is a health sciences company active in genomics, diagnostics, and consumer…

Innovation pipeline, portfolio in focus ahead of Johnson & Johnson’s Q3 earnings

For Johnson & Johnson (NYSE: JNJ), 2025 has been a strong year, marked by an impressive financial performance that drove…

Earnings Summary: AngioDynamics (ANGO) reports Q1 loss; sales up 12.2%

Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Thursday reported a net loss for the first quarter of 2026. Revenues…

McKesson Corporation (MCK) raises FY26 earnings guidance

McKesson Corporation (NYSE: MCK), a diversified healthcare service company that operates in partnership with biopharma companies and care providers, has…

Inspire Veterinary Partners has a focus on long-term relationship with stakeholders: CEO

Inspire Veterinary Partners (NASDAQ: IVP) operates a growing network of veterinary hospitals across the US, specializing in small animal care…

Earnings Summary: Agilent (A) reports higher Q3 2025 revenue and profit

Healthcare company Agilent Technologies Inc. (NYSE: A) has reported higher revenue and adjusted earnings for the third quarter of fiscal…

Earnings Summary: A snapshot of CooperCompanies’ (COO) Q3 2025 report

Medical device maker CooperCompanies (NYSE: COO) has reported a double-digit increase in adjusted earnings for the third quarter of 2025…

IPO News: Picard Medical files for US IPO amid growth push

After a modest start to the year, IPO activity gained momentum in the second quarter, despite lingering macro headwinds and…

MDT Earnings: Medtronic Q1 2026 adj. profit rises on higher sales

Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported an increase in net sales and adjusted earnings for the…

Earnings Summary: Cardinal Health reports higher Q4 earnings and flat revenues

Cardinal Health (NYSE: CAH), a leading pharmaceuticals distributor, on Tuesday reported an increase in adjusted profit for the fourth quarter…

Key highlights from Eli Lilly’s (LLY) Q2 2025 earnings results

Eli Lilly and Company (NYSE: LLY) reported its second quarter 2025 earnings results today. Worldwide revenue was $15.56 billion, up…

Strategic partnerships have been essential to Profusa’s progress: CEO Ben Hwang

Profusa, Inc. (NASDAQ: PFSA) is a digital health company pioneering a new generation of biointegrated sensors. Its injectable biosensors are…

Eli Lilly (LLY) set to report Q2 2025 results. Here’s what to expect

Eli Lilly and Company (NYSE: LLY) had a positive start to fiscal 2025, reporting strong revenue and earnings growth for…

PFE Earnings: All you need to know about Pfizer’s Q2 2025 earnings results

Pfizer Inc. (NYSE: PFE) reported its second quarter 2025 earnings results today. Revenues were $14.7 billion, up 10% year-over-year. Reported…